BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.41% |
| 2 | Financials | 6.99% |
| 3 | Consumer Discretionary | 5.47% |
| 4 | Healthcare | 5.09% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
3101
DELISTED
Catalyst Pharmaceutical
CPRX
| $81.2K | ﹤0.01% |
15,294
+3,896
| +34% | +$20.8K |
|
3102
VanEck Indonesia Index ETF
IDX
$36.6M
| $81.1K | ﹤0.01% |
3,738
-2,465
| -40% | -$55.7K |
|
3103
National Presto Industries
NPK
$1.01B
| $80.9K | ﹤0.01% |
908
+242
| +36% | +$21.9K |
|
|
KREF
3104
KKR Real Estate Finance Trust
KREF
$507M
| $80.5K | ﹤0.01% |
4,120
-98
| -2% | -$1.93K |
|
3105
Manitowoc
MTW
$765M
| $80.4K | ﹤0.01% |
6,432
-177
| -3% | -$2.67K |
|
|
GNC
3106
PUT
DELISTED
GNC Holdings, Inc.
GNC
| $80.3K | ﹤0.01% |
375
| – | – |
|
|
MAXR
3107
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $80.2K | ﹤0.01% |
10,558
+122
| +1% | +$968 |
|
|
ACH
3108
Accendra Health
ACH
$82.3M
| $80.1K | ﹤0.01% |
13,792
-8,625
| -38% | -$38.7K |
|
3109
MYR Group
MYRG
$5.16B
| $80.1K | ﹤0.01% |
2,559
+186
| +8% | +$5.99K |
|
3110
UroGen Pharma
URGN
$2.29B
| $80K | ﹤0.01% |
+3,359
| New | +$110K |
|
3111
Goosehead Insurance
GSHD
$2.34B
| $79.9K | ﹤0.01% |
1,619
+500
| +45% | +$23K |
|
|
ATRS
3112
DELISTED
Antares Pharma, Inc.
ATRS
| $79.7K | ﹤0.01% |
23,819
+6,715
| +39% | +$22.1K |
|
3113
CryoPort
CYRX
$763M
| $79.5K | ﹤0.01% |
4,862
+1,805
| +59% | +$36.2K |
|
3114
The Bancorp
TBBK
$2.85B
| $79.2K | ﹤0.01% |
8,000
+1,968
| +33% | +$18.7K |
|
|
QADA
3115
DELISTED
QAD Inc.
QADA
| $78.9K | ﹤0.01% |
1,708
+187
| +12% | +$7.79K |
|
|
DO
3116
DELISTED
Diamond Offshore Drilling
DO
| $78.9K | ﹤0.01% |
14,182
+3,212
| +29% | +$23.5K |
|
3117
Dime Commercial Bancshares
DCOM
$1.83B
| $78.7K | ﹤0.01% |
2,663
-49
| -2% | -$1.39K |
|
3118
Phibro Animal Health
PAHC
$1.39B
| $78.6K | ﹤0.01% |
3,683
+678
| +23% | +$18.6K |
|
3119
Karyopharm Therapeutics
KPTI
$45.1M
| $78.6K | ﹤0.01% |
544
+182
| +50% | +$24.7K |
|
3120
Select Water Solutions
WTTR
$2.69B
| $78.5K | ﹤0.01% |
9,064
+1,857
| +26% | +$17K |
|
3121
Kura Oncology
KURA
$901M
| $78.4K | ﹤0.01% |
5,170
+2,036
| +65% | +$36.2K |
|
|
WTRE
3122
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $78.2K | ﹤0.01% |
2,902
+1,926
| +197% | +$47K |
|
3123
BRC Group Holdings
RILY
$304M
| $78K | ﹤0.01% |
3,304
+18
| +0.5% | +$381 |
|
3124
PUT
Lockheed Martin
LMT
$139B
| $78K | ﹤0.01% |
2
-7
| -78% | -$2.63K |
|
|
TPIC
3125
DELISTED
TPI Composites
TPIC
| $78K | ﹤0.01% |
4,160
+2,334
| +128% | +$49.8K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.